Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA DIETARY SUPPLEMENT INSPECTIONS: 54% INITIATED BY COMPLAINTS

This article was originally published in The Tan Sheet

Executive Summary

FDA DIETARY SUPPLEMENT INSPECTIONS: 54% INITIATED BY COMPLAINTS to the agency's Denver and Los Angeles district offices, according to a General Accounting Office report on FDA regulation of dietary supplements. The report, which was mandated by the Dietary Supplement Act of 1992, notes that the remaining 46% of FDA inspections of dietary supplement establishments in the Denver and Los Angeles districts were "scheduled by the districts as part of their routine compliance work."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel